01-08-2007 | Original Article
Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation
Published in: Annals of Hematology | Issue 8/2007
Login to get access